Plastics Maker’s CFO Balances Cyclicality vs. R&D Imperative
Covestro, pressed by low pricing for its products, continues its focus on sustainability-oriented products that don’t necessarily convert quickly to profit.
How CFOs Can Unlock Innovation
The most important thing CFOs and other leaders can do is give people the right resources and remove the obstacles that allow them to innovate.
Gilead to Invest $5B in Galapagos Partnership
The deal expands Gilead's investment in the European biotech as it seeks to add assets to its drug portfolio.
The CFO’s Crucial Role in Digital Transformation
The need to decide what funding requests to prioritize and how much to invest puts finance chiefs squarely in the middle of digital transformation efforts.
Wall Street’s ‘Short Termism’ Misses the Point
Beating earnings estimates quarter after quarter doesn't have much to do with long-term shareholder value.
New CFO Works Overtime to Learn His New Industry
Jamey Mock came to life-sciences company PerkinElmer from General Electric. It's a mind-bending change, but of a type the finance chief is familiar with.
Repatriated Cash Should Boost R&D Spending
The new tax break on repatriated foreign earnings will spur increased R&D, a study of an earlier tax holiday suggests.
To Make More Money, CEOs Harm Company Value
Quarters when CEO equity awards vest coincide with corporate actions that pump up stock prices briefly while damaging the company's long-term value.
Capital Gets a Reset
Among a number of capital-raising experiments, some companies are seeking investors for specific projects.
Eli Lilly to Trim 3,500 Jobs to Save $500 Million
The drugmaker is seeking to become "a leaner, more nimble global organization" as it invests in a new generation of medicines.
Why Great Health Care Companies Aren’t Necessarily Great Stocks
Performance metrics related to improvement or growth demonstrate the most positive relationships to shareholder return.